Business
Wegovy maker warns of 'painful' price cuts as shares plunge
Novo Nordisk is facing “unprecedented” price pressures, “intensifying competition” and patents expiring.
Novo Nordisk is facing “unprecedented” price pressures, “intensifying competition” and patents expiring.